Today I'll offer a stock idea in the genetic research field. Santa Clara, California,-based Affymetrix (NASDAQ:AFFX), a leading player and pioneer in developing and selling genomics research analysis equipment, is poised to be an excellent turnaround story. After years of accumulated debt and declining revenues, the company has finally undertaken a long-term strategy for returning to profitability.
It appears to me that Affymetrix is incredibly cheap in light of its turnaround initiative as its restructuring and debt reduction efforts should boost its financial performance significantly going forward. It seems the company is moving in the right direction. I believe the stock could turn out to be a multi-bagger if the turnaround initiative becomes successful, which looks like a
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|